
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics (DGX) navigates strategic acquisitions, innovation, and an upcoming Investor Day, shaping its diagnostic leadership and market outlook.
Quest Diagnostics expands through strategic acquisitions and partnerships, focusing on cancer and Alzheimer's diagnostics. Investor Day preview and financial analysis included.
Quest Diagnostics strategically expands through acquisitions, partnerships, and innovation in Alzheimer's and cancer diagnostics. Investor Day 2025 promises insights into future strategies.
Quest Diagnostics strategically expands with Spectra Laboratories acquisition and GRAIL partnership, innovating in Alzheimer's diagnostics. Investor Day insights awaited.
Comprehensive update on DGX's latest innovations, strategic partnerships, Q4 earnings, and market trends driving diagnostic growth.
Quest Diagnostics navigates market dynamics with strategic collaborations and innovation, focusing on growth in diagnostics and Alzheimer's research.